← Eichor
Study identifier: NCT06489665 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Imaging Quality and Potential Clinical Relevance of Phase Contrast Mammography In-vivo: a Single-center, Prospective Study

Condition: Breast Cancer · Microcalcification · Image  ·  Sponsor: University of Zurich

PhaseN/A
Planned participants350
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Conventional mammography, breast sonography and breast MRI have specific weaknesses. In particular, mammography has a low sensitivity for the detection of mammary carcinoma in patients with a dense breast. Phase contrast mammography could help to overcome some of these limitations. Observational study.

This description comes directly from the study's public registry record.

Talk to the study team

Thomas Frauenfelder, Prof  ·  +41 44 255 93 83  ·  thomas.frauenfelder@usz.ch

Judith Jehle  ·  0763257051  ·  judith.jehle@usz.ch

Always discuss trial participation with your own doctor first.

Locations (2)

University Hospital Zurich - Diagnostic RadiologyZurich, Canton of Zurich, SwitzerlandRecruiting
University of ZurichZurich, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06489665